Product image of Levothyroxine Brillpharma (Levothyroxine Sodium) supplied by GNH India

Levothyroxine Brillpharma

Active Ingredient:
Levothyroxine Sodium
Origin:
EU

Levothyroxine Brillpharma (Levothyroxine Sodium)

Levothyroxine Sodium, the active ingredient in Levothyroxine Brillpharma, is a thyroid hormone presented as a tablet for oral use. It treats hypothyroidism and provides hormone replacement after thyroidectomy or in goiter patients.
GNH India supplies Levothyroxine Brillpharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Brillpharma Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levothyroxine Brillpharma acts on the thyroid hormone pathway to restore normal metabolic function.

  • Hypothyroidism: normalizes thyroid hormone levels and alleviates symptoms such as fatigue and weight gain.
  • Post‑thyroidectomy replacement: supplies the missing thyroxine after surgical removal of the thyroid gland.
  • Goiter: reduces gland enlargement by providing adequate hormone feedback.

How It Works

  • Levothyroxine Sodium is a synthetic form of thyroxine (T4). After oral absorption, it is converted in peripheral tissues to the active hormone triiodothyronine (T3). The resulting increase in circulating thyroid hormones binds nuclear receptors, modulating gene transcription and restoring normal basal metabolic rate in patients with deficient endogenous production.

Side Effects

Levothyroxine may cause a range of adverse reactions, most of which are dose‑related.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Nervousness or anxiety: especially during dose titration.
  • Insomnia: difficulty falling or staying asleep.
  • Weight loss: unintended reduction in body weight.
  • Palpitations: awareness of rapid heartbeat.
  • Heat intolerance: increased sensitivity to warm environments.

Serious or Rare Side Effects

  • Cardiac arrhythmia: irregular heart rhythm, potentially life‑threatening.
  • Angina or myocardial infarction: chest pain or heart attack in susceptible patients.
  • Severe bone loss (osteoporosis): increased fracture risk with long‑term overtreatment.
  • Allergic reaction: rash, swelling, or anaphylaxis.
  • Thyrotoxic crisis (thyroid storm): acute, severe hyperthyroid state.
  • Severe hypercalcemia: elevated calcium levels in rare cases.

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety factors.

  • Dose adjustment: individualize based on serum TSH and free T4 levels.
  • Cardiovascular disease: monitor for tachycardia, angina, or arrhythmias.
  • Elderly patients: start with a lower dose and titrate slowly.
  • Pregnancy: use only when the benefit outweighs potential risk to the fetus.
  • Drug interactions: review concomitant medications that may affect absorption or metabolism.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Levothyroxine's absorption and activity can be altered by several medicines.

Major Interactions (Avoid)

  • Antithyroid drugs (e.g., propylthiouracil): antagonize therapeutic effect.
  • Calcium supplements or antacids: reduce levothyroxine absorption.
  • Iron supplements: impair intestinal uptake.
  • Amiodarone: may cause unpredictable changes in thyroid hormone levels.
  • Warfarin: levothyroxine can increase anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask symptoms of excess thyroid hormone.
  • Corticosteroids: increase metabolic clearance of levothyroxine.
  • Estrogen therapy: raises thyroid‑binding globulin, potentially lowering free hormone.
  • Lipid‑lowering agents (e.g., cholestyramine): decrease drug absorption.
  • Serotonergic agents: rare reports of precipitating thyroid storm.

Frequently Asked Questions

Levothyroxine Brillpharma is prescribed to replace deficient thyroid hormone in patients with hypothyroidism, to provide hormone replacement after total or partial thyroidectomy, and to manage goiter by normalizing thyroid feedback mechanisms.

Levothyroxine Sodium is a synthetic form of thyroxine (T4). After oral absorption, it is converted to the active hormone triiodothyronine (T3) in peripheral tissues, which then binds nuclear thyroid receptors to regulate gene expression and restore normal metabolic activity.

The appropriate dose of Levothyroxine Brillpharma is individualized and set by the prescribing clinician based on the patient’s serum TSH, free T4 levels, age, weight, cardiac status, and other clinical factors.

Levothyroxine is generally considered safe in pregnancy when needed to treat maternal hypothyroidism, as untreated disease poses greater risk. Use during breastfeeding is also acceptable, but the prescriber should weigh benefits against any potential risks.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levothyroxine provides synthetic T4, which the body converts to T3 as needed, offering a stable and predictable replacement. Alternatives such as liothyronine (synthetic T3) act more rapidly but may cause greater fluctuations. Combination therapy is sometimes used, but levothyroxine remains the standard first‑line agent.

Store the tablets at ambient temperature, preferably below 25 °C, in the original blister pack or container. Protect from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf life.

Levothyroxine Brillpharma is taken orally, usually on an empty stomach, at least 30‑60 minutes before breakfast. The tablet should be swallowed whole with a full glass of water and not crushed or chewed.

Serious risks include cardiac arrhythmias, angina, myocardial infarction, severe bone loss (osteoporosis) with long‑term overtreatment, allergic reactions, and rare thyrotoxic crisis. Patients should report chest pain, rapid heartbeat, severe bone pain, or signs of an allergic response immediately.

Levothyroxine is contraindicated in patients with uncorrected adrenal insufficiency, untreated thyrotoxicosis, or known hypersensitivity to levothyroxine or any excipients in the tablet. Caution is also advised for individuals with recent myocardial infarction or severe cardiovascular disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levothyroxine Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT